SHEFA RAHMAN: Open Payments
NPI 1124461942 · FAYETTEVILLE, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$550 in 30 payments from 6 companies in 2025. Trend: 2023 $1,915 · 2024 $453 · 2025 $550
Food & beverage: $550
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 11 | $215 |
| Alkermes, Inc. | 10 | $144 |
| E.R. Squibb & Sons, L.L.C. | 4 | $72 |
| Teva Pharmaceuticals USA, Inc. | 2 | $56 |
| Janssen Pharmaceuticals, Inc | 2 | $50 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
Products named: ARISTADA, HETLIOZ, FANAPT, COBENFY, UZEDY, INVEGA SUSTENNA, VIVITROL, ABILIFY ASIMTUFII.
Industry payments across AR — which companies pay providers there.
